ArticleAnimal bioscience2026
Insights into nanostructured lipid carriers for the effective delivery of bioactives in swine and poultry health: review.
Article in Animal bioscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A meta-analysis ofVeterinary and animal science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Nanostructured lipid carriers (NLCs) are promising in target and efficient delivery of bioactive compounds with high loading capacity of bioactives, better physical stability, better encapsulation efficiency, solubility and bioavailability in comparison to the traditional delivery systems for lipophilic and hydrophobic bioactives such as essential oils and phytochemicals as well as functional feed ingredients. There are different types of NLCs combining solid lipid and liquid lipid in a single nanoparticulate matrix that have advantages over other drug delivery systems. The NLCs can be synthesized in form of imperfect, amorphous, oil-enriched, surface modified or functionalized, hybrid or composite and multiple-compartment or double-shell NLCs. Moreover, the synthesized NLCs safety, efficacy, toxicity, encapsulation efficiency, drug loading and releasing capacity, reproducibility in large scale were evaluated. The application of NLCs for the effective and target delivery of bioactive compounds are widely reported in biomedical and therapeutic studies. However, utilization of NLCs for the effective delivery of bioactive compounds is very limited in swine and poultry health. There are some recent studies reported that NLCs with can enhance growth, antioxidant capacity, immunity, gut health and microbiome as well as disease resistance in swine and poultry. This review focuses on recent developments and future prospects of utilizing NLCs in swine and poultry health management. Regardless of the potential beneficial effects of NLCs in nanodelivery of bioactive compounds, further research on long-term field oriented studies in livestock and poultry farms and economic analysis of manufactured NLCs should be conducted.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.